Virax Biolabs Group Ltd (VRAX) Net margin 2021–2025
Virax Biolabs Group Ltd (VRAX) net profit margin by fiscal year — reported net income divided by reported revenue.
-95739.2%FY2025 · since FY2021: -525.8% → -95739.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -95739.2% | -91434.4 pp |
| FY2024 | -4304.8% | +59443.5 pp |
| FY2023 | -63748.3% | — |
| FY2021 | -525.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More VRAX financial trends
VRAX RevenueVRAX Net incomeVRAX Gross profitVRAX Gross marginVRAX Operating incomeVRAX Operating marginVRAX Operating cash flowVRAX Free cash flowVRAX Capital expendituresVRAX Return on equityVRAX Stock buybacksVRAX Dividends paidVRAX Total assetsVRAX Total liabilitiesVRAX Shareholders’ equityVRAX overview →